Table 1.

Baseline characteristics of the 24 included participants in the three intervention groups.

	Group A (n = 8) prednisolone placebo + curcumin placebo (mean ± s.d.)	Group B (n = 8) prednisolone + curcumin placebo (mean ± s.d.)	Group C (n = 8) prednisolone + curcumin (mean ± s.d.)
Age (years)	41.6 ± 9.8	44.0 ± 13.5	47.0 ± 17.8
BMI (kg/m2)	30.4 ± 4.3	30.3 ± 3.3	29.3 ± 3.2
HOMA2-IR	1.17 ± 0.50	1.2 ± 0.53	0.94 ± 0.31
Fasting plasma glucose (mmol/L)	5.15 ± 0.42	5.37 ± 0.41	4.99 ± 0.41
Hepatic fat content (%)	3.1 ± 2.5	3.1 ± 3.0	2.4 ± 2.3
HbA1c (mmol/mol)	34.4 ± 2.3	32.0 ± 3.4	33.4 ± 3.7

HbA1c, glycated haemoglobin A1c; HOMA2-IR, homeostatic model assessment of insulin resistance. HbA1c, glycated haemoglobin A1c; HOMA2-IR, homeostatic model assessment of insulin resistance.